SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

CANO CHRISTOPHER

(Last)

(First)

(Middle)

2600 VIA FORTUNA, SUITE 360

(Street)

AUSTIN

78746

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/24/2020

3. Issuer Name and Ticker or Trading Symbol
TFF Pharmaceuticals, Inc. [ TFFP ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Operating Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	⁽¹⁾	02/01/2029	Common Stock	8,500	$2.5	D
Stock Option (Right to Buy)	⁽²⁾	12/19/2029	Common Stock	30,000	$5.16	D
Stock Option (Right to Buy)	⁽³⁾	06/24/2030	Common Stock	30,000	$5.81	D
Stock Option (Right to Buy)	⁽⁴⁾	08/23/2030	Common Stock	10,000	$13.65	D
Stock Option (Right to Buy)	⁽⁵⁾	09/10/2030	Common Stock	78,500	$14.06	D

Explanation of Responses:

1. 3,187 shares have vested on August 1, 2020 and the remainder of shares scheduled to vest at an approximate rate of 531 every three months thereafter.

2. Each Option shall vest and first become exercisable as follows: one quarter of the Option shall vest and first become exercisable on December 20, 2020 and the remainder of the Option shall vest and become exercisable in 12 equal quarterly installments commencing on March 20, 2021.

3. Each Option shall vest and first become exercisable as follows: one quarter of the Option shall vest and first become exercisable on June 25, 2021 and the remainder of the Option shall vest and become exercisable in 12 equal quarterly installments commencing on September 25, 2021.

4. Each Option shall vest and first become exercisable as follows: one quarter of the Option shall vest and first become exercisable on August 24, 2021 and the remainder of the Option shall vest and become exercisable in 12 equal quarterly installments commencing on November 24, 2021.

5. Each Option shall vest and first become exercisable as follows: one quarter of the Option shall vest and first become exercisable on September 11, 2021 and the remainder of the Option shall vest and become exercisable in 12 equal quarterly installments commencing on December 11, 2021.

	/s/Christopher Cano	09/29/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.